These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 15380032)

  • 1. Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients?
    van de Loo FA; Smeets RL; van den Berg WB
    Arthritis Res Ther; 2004; 6(5):183-96. PubMed ID: 15380032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy works in animal models of rheumatoid arthritis...so what!
    van de Loo FA; Geurts J; van den Berg WB
    Curr Rheumatol Rep; 2006 Oct; 8(5):386-93. PubMed ID: 16973113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-β (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis.
    Aalbers CJ; Bevaart L; Loiler S; de Cortie K; Wright JF; Mingozzi F; Tak PP; Vervoordeldonk MJ
    PLoS One; 2015; 10(6):e0130612. PubMed ID: 26107769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
    Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D
    Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of established collagen-induced arthritis with a tumour necrosis factor-alpha inhibitor expressed from a self-contained doxycycline regulated plasmid.
    Gould DJ; Bright C; Chernajovsky Y
    Arthritis Res Ther; 2004; 6(2):R103-13. PubMed ID: 15059273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of cellular gene therapy for rheumatoid arthritis.
    Nakajima A
    Mod Rheumatol; 2006; 16(5):269-75. PubMed ID: 17039306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for rheumatoid arthritis: current status and future prospects.
    Fabre S; Apparailly F
    BioDrugs; 2011 Dec; 25(6):381-91. PubMed ID: 22050340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor alpha and reduces arthritis.
    Zhang HG; Xie J; Yang P; Wang Y; Xu L; Liu D; Hsu HC; Zhou T; Edwards CK; Mountz JD
    Hum Gene Ther; 2000 Nov; 11(17):2431-42. PubMed ID: 11096446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing the concept of adoptive cellular gene therapy of rheumatoid arthritis.
    Tarner IH; Neumann E; Gay S; Fathman CG; Müller-Ladner U
    Autoimmun Rev; 2006 Feb; 5(2):148-52. PubMed ID: 16431349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy in rheumatic diseases.
    Vervoordeldonk MJ; Tak PP
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):771-88. PubMed ID: 11812021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic gene transfer for rheumatoid arthritis.
    Boissier MC; Bessis N
    Reumatismo; 2004; 56(1 Suppl 1):51-61. PubMed ID: 15201941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lentivirus-mediated delivery of short hairpin RNA targeting calcium release-activated calcium channel 3 as gene therapy for collagen-induced arthritis.
    Liu S; Kiyoi T; Takemasa E; Maeyama K
    J Immunol; 2015 Jan; 194(1):76-83. PubMed ID: 25422506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes.
    Adriaansen J; Vervoordeldonk MJ; Tak PP
    Rheumatology (Oxford); 2006 Jun; 45(6):656-68. PubMed ID: 16510530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of arthritis by intraarticular dominant negative Ikk beta gene therapy using adeno-associated virus type 5.
    Tas SW; Adriaansen J; Hajji N; Bakker AC; Firestein GS; Vervoordeldonk MJ; Tak PP
    Hum Gene Ther; 2006 Aug; 17(8):821-32. PubMed ID: 16942442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SCID mouse model: novel therapeutic targets - lessons from gene transfer.
    Pierer M; Müller-Ladner U; Pap T; Neidhart M; Gay RE; Gay S
    Springer Semin Immunopathol; 2003 Aug; 25(1):65-78. PubMed ID: 12904892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of rheumatoid synovium in situ using a Fas ligand 'gene scalpel'.
    Zhang H; Gao G; Clayburne G; Schumacher HR
    Arthritis Res Ther; 2005; 7(6):R1235-43. PubMed ID: 16277676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-articular electrotransfer of mouse soluble tumour necrosis factor receptor in a murine model of rheumatoid arthritis.
    Denys A; Thiolat A; Descamps D; Lemeiter D; Benihoud K; Bessis N; Boissier MC
    J Gene Med; 2010 Aug; 12(8):659-68. PubMed ID: 20623491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for gene therapy in inflammatory arthritis.
    Jorgensen C; Apparailly F
    Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):541-52. PubMed ID: 20732651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer to human joints: progress toward a gene therapy of arthritis.
    Evans CH; Robbins PD; Ghivizzani SC; Wasko MC; Tomaino MM; Kang R; Muzzonigro TA; Vogt M; Elder EM; Whiteside TL; Watkins SC; Herndon JH
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8698-703. PubMed ID: 15939878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.